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Delays in the diagnosis of tuberculosis (TB) contribute to a substantial proportion of TB-
related mortality, especially among people living with HIV (PLHIV). We sought to character-
ize the diagnostic journey for HIV-positive and HIV-negative patients with a new TB diagno-
sis in Zambia, to understand drivers of delay, and characterize their preferences for service
characteristics to inform improvements in TB services.
Methods
We assessed consecutive adults with newly microbiologically-confirmed TB at two public
health treatment facilities in Lusaka, Zambia. We administered a survey to document critical
intervals in the TB care pathway (time to initial care-seeking, diagnosis and treatment initia-
tion), identify bottlenecks and their reasons. We quantified patient preferences for a range of
characteristics of health services using a discrete choice experiment (DCE) that assessed 7
attributes (distance, wait times, hours of operation, confidentiality, sex of provider, testing
incentive, TB test speed and notification method).
Results
Among 401 patients enrolled (median age of 34 years, 68.7% male, 46.6% HIV-positive),
60.9% and 39.1% were from a first-level and tertiary hospital, respectively. The median time
from symptom onset to receipt of TB treatment was 5.0 weeks (IQR: 3.6–8.0) and was lon-
ger among HIV-positive patients seeking care at a tertiary hospital than HIV-negative
patients (6.4 vs. 4.9 weeks, p = 0.002). The time from symptom onset to initial presentation
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The DCE found that patients strongly preferred same-day TB test results (relative
importance, 37.2%), facilities close to home (18.0%), and facilities with short wait times
(16.9%). Patients were willing to travel to a facility up to 7.6 kilometers further away in
order to access same-day TB test results. Preferences for improving current TB services
did not differ according to HIV status.
Conclusions
Prolonged intervals from TB symptom onset to treatment initiation were common, especially
among PLHIV, and were driven by delayed health-seeking. Addressing known barriers to
timely diagnosis and incorporating patients’ preferences into TB services, including same-
day TB test results, may facilitate earlier TB care engagement in high burden settings.
Introduction
Tuberculosis (TB) killed an estimated 1.4 million individuals in 2019 and it remains the lead-
ing cause of death among people living with HIV (PLHIV) [1]. Delayed and missed TB diag-
noses contribute to poor outcomes among predominantly socioeconomically vulnerable
individuals, including prolonged suffering and mortality [2–4], as well as ongoing community
transmission [5]. Therefore, continued progress in the fight against TB cannot be achieved
without finding the missing persons with TB and identifying them sooner [3,5,6].
For individuals with undiagnosed TB, the pathway to care engagement may be long and
complex as they often face numerous barriers to seeking care for their illness and accessing TB
services [7–9]. These may include (among others): lack of knowledge about TB and its conse-
quences, TB- and HIV-related stigma concerns, cultural and gender norms related to health-
care seeking, poverty and the direct and indirect costs of healthcare seeking, as well as
perceptions that facilities do not meet their needs, including inflexible hours, long waiting
times, judgmental or rude staff, and privacy and confidentiality concerns [7–10]. In order to
design interventions that may improve health-seeking behavior for TB, it is important to
understand contextually-specific barriers faced by individuals engaging in TB services, and
also what intervention components would be the most preferred and acceptable. Discrete
choice experiments (DCEs) are a quantitative method that quantifies patients’ preferences and
allow trade-offs between program or intervention components to be evaluated [11,12]. How-
ever, to date, no study has undertaken a DCE among TB patients in order understand their
preferences for improving TB care engagement.
TB is a leading cause of mortality in Zambia, especially among PLHIV who account for
more than 60% of the annual 15,400 TB-related deaths [1,13]. We have previously identified
that the largest gap in Zambia’s national TB care cascade (~73% of missed cases) is due to a
lack of health-seeking and/or lack of access to TB diagnostic testing [14]. Yet, patient care jour-
neys to TB diagnosis and treatment initiation for individuals in Zambia, including how they
may differ according to HIV status, are not well defined. Furthermore, patients’ preferences
for improving TB services are poorly understood. Thus, we sought to characterize the critical
intervals in the pathways to care among newly diagnosed TB patients in Zambia, in order to
identify potential bottlenecks, barriers they faced and understand whether these differed
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according to HIV status. We also undertook a DCE in order to determine patients’ preferences
for improving TB services that could accelerate care engagement.
Methods
Setting and participants
This prospective cross-sectional study was undertaken at two public health facilities in Lusaka,
Zambia from September 2019 to January 2020. Kanyama TB clinic is a busy outpatient TB
clinic based at a first-level hospital that serves as the primary health facility for a large densely
populated peri-urban township [15]. University Teaching Hospital (UTH) is a large tertiary
referral hospital that serves all of Lusaka and has more than 1,600 beds.
Eligible participants were those aged�18 years, had microbiologically-confirmed TB, and
had started on anti-TB therapy in the last 2 weeks (to reduce recall bias). Patients classified as a
retreatment TB case (e.g., default, failure, lost-to-follow-up) were excluded due to potentially
non-representative health-seeking and care experiences.
Ethics, consent and permissions
All participants provided written informed consent in their preferred language (Bemba,
Nyanja, or English). The study was approved by the University of Zambia Biomedical Research
Ethics Committee (#010-014-19) and the institutional review board of the University of Cali-
fornia, San Francisco (#18–26028).
Procedures and survey
Participants completed a structured survey followed by a DCE. Surveys and DCEs were
administered to participants using an electronic touchscreen tablet with the help of a trained
research assistant. Surveys captured socio-demographic details and medical history (S1
Appendix). To understand patient pathways to care, surveys asked participants about their TB
symptoms, timing of symptom onset, all care-seeking actions undertaken after symptom onset
until TB diagnosis (and relative timing), as well as barriers and facilitators to seeking care for
their TB illness and accessing TB care services. Additional details related to TB diagnosis and
treatment history were extracted from facility-specific TB registers.
DCE attribute selection and design
A DCE was administered to understand which potential features to improve TB services were
most preferred by TB patients and could potentially improve health-seeking behaviors and
result in earlier TB care engagement. TB health facility attributes and levels were informed by
a literature review and discussions with key stakeholders [11]. The DCE design featured seven
different TB service attributes that differed according to two to three levels (Table 1).
The DCE was designed using Lighthouse Studio Version 9.7.2 (Sawtooth Software, Provo,
USA). The final design was near balanced and orthogonal with respect to attributes and attri-
bute levels [16]. Each participant was shown one of 400 randomly drawn choice sets comprised
of 9 choice tasks [17]. Pictures accompanied all attributes and levels to enhance
comprehension.
DCE sample size estimation
The minimum sample size necessary for the DCE was determined in two ways. First, using the
formula, “n� 500c/ta,” where ‘n’ is the number of patients, ‘t’ is the number of choice tasks, ‘a’
is the number of options per choice task, and ‘c’ is the product of the greatest number of levels
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for any two attributes (when considering all two-way interactions) [12]; this resulted in a
required sample size of n = 250 [(500 x 9)/(2x9)]. However, based upon the observation that
there is limited improvement in estimate precision when a sample size of n = 300 is exceeded,
a minimum of 300 participants is generally recommended if there are no planned subgroup
analyses, or at least 200 participants per subgroup when subgroup analyses are planned
[12,16,17]. As this study sought to evaluate differences in preferences according to HIV status,
we aimed to recruit n = 400 (2�200) participants for inclusion.
Definitions
‘Microbiologically-confirmed TB’ was defined by the detection of Mycobacterium tuberculosis
using Xpert MTB/RIF or culture on any clinical specimen, and/or a positive sputum smear
microscopy and/or urine Determine TB-LAM result. The ‘TB care pathway’ was defined as the
time from self-reported symptom onset to initiation of TB therapy. ‘Health-seeking delay’ was
defined as the time from symptom onset to initial care-seeking, ‘diagnostic delay’ was defined
as the time from initial care-seeking to TB diagnosis, and ‘treatment delay’ was defined as the
time from TB diagnosis to initiation of TB therapy.
Analysis
We were a priori interested in evaluating whether patients’ TB care pathways, barriers and
facilitators to TB care engagement and preferences differed according to HIV status. However,
due to differences in baseline characteristics by enrollment site, analyses are presented both
overall and according to HIV status by enrollment site. Proportions were compared using
either Fisher’s exact tests or Pearson’s chi-squared tests as appropriate; median values were
compared using Wilcoxon rank-sum tests. For the DCE, a hierarchical Bayesian (HB) model
was used to estimate part-worth utilities as well as the relative importance of each facility’s
attributes [12]. Sub-group analyses were undertaken to evaluate whether patient preferences
differed according to HIV status, sex, or time to seeking care after symptom-onset (<4 weeks,
�4 weeks) and were adjusted to account for differences by enrolment site. We then incorpo-
rated the calculated individual part-worth utilities into Sawtooth’s choice simulator tool to
determine the additional distance participants would be willing to travel (in kilometers) or
Table 1. Discrete choice experiment attributes and attribute levels to evaluate patient preferences for improving tuberculosis services in Zambia.
Attributes Levels
1. Distance to facility (from home) 2 kilometers 6 kilometers 10 kilometers
2. Confidentiality A place where no one knows
who I am
A place where I may be known or recognized
3. Hours of facility operation Normal weekday hours Normal weekday hours + extended early
morning or evening hours
Normal weekday hours + open
Saturdays
4. Sex of provider The healthcare provider is the
same sex as I am
The healthcare provider may be either a man
or a woman
5. Total time spent at facility (waiting and
undertaking evaluation)
2 hours 5 hours 8 hours
6. Incentive for undertaking TB testing 0 Kwacha 30 Kwacha (~$2USD) 60 Kwacha (~$4USD)
7. TB test results (speed and notification
method)
TB testing results available
before you leave
Contacted by phone with TB results and
return instructions
Must return another day to
facility for TB results
Prior to administering the discrete choice experiment, participants were asked to imagine that they were feeling sick again with their prior TB symptoms and they were
then asked to choose at which one of the two facilities they would prefer to be evaluated. For each task, a participant was asked to select facility A or facility B based upon
the different attribute levels shown, however, a participant could also select, "none, I wouldn’t choose either of these,” if neither hypothetical facility was acceptable.
https://doi.org/10.1371/journal.pone.0252095.t001
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additional time they were willing to wait (in hours) in order to access enhanced healthcare
facility features (attribute levels) [18].
Results
Baseline characteristics
Of 483 adults with newly confirmed TB recruited for study participation, 401 agreed to partici-
pate, had complete survey results, and were included (Fig 1); 60.8% were enrolled from the
first level hospital, while 39.1% were enrolled from the tertiary hospital. TB patients tended to
be young (median age 34 years), 68.7% were male, 46.6% were HIV-positive, and 14.3% had
previously been treated for TB (Table 2).
Patient characteristics differed substantially by enrollment site and HIV status (Table 2).
HIV-positive TB patients tended to be older and have a previous history of TB compared to
HIV-negative TB patients, whilst the large majority of HIV-negative TB patients were men
(Table 2). HIV-positive TB patients attending the tertiary hospital were more likely to have
been diagnosed with HIV in the last 12 months than those attending the first-level facility
(42.2% vs. 28.6%).
Duration of TB care pathways
The median duration of the TB care pathway among all patients was 5.0 (interquartile range
[IQR], 3.6–8.0) weeks (Fig 2 and S1a Fig). While 71.0% of patients had a total TB care pathway
of less than 8 weeks, 18.2% and 10.8% had a pathway lasting 8–11.9 weeks and�12 weeks,
respectively (Table 3). This did not differ by HIV status among patients attending the first level
Fig 1. Study flow diagram.
https://doi.org/10.1371/journal.pone.0252095.g001
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hospital; however, among those attending the tertiary hospital, HIV-positive patients experi-
enced a substantially longer period of time from symptom onset to initiation of TB therapy
than HIV-negative patients (6.4 vs. 4.9 weeks, p = 0.002) (Table 3, Fig 2 and S1a Fig). HIV-
positive patients attending the tertiary hospital also had longer pathways than HIV-positive
patients seeking care at the first-level hospital (6.4 vs. 4.1 weeks, p = 0.012).
Health-seeking delays (patient-related delays)
The majority of the time spent along the TB care pathway was due to patient-related delays in
health-seeking (Fig 2 and S1b Fig). The overall median time from symptom onset to initial
care-seeking was 3.0 weeks (IQR, 1.0–5.0). Most patients sought care for their TB illness within
4 weeks of symptom onset (58.7%), but 30.3% waited 4–7.9 weeks to first seek care, and 11.0%
waited�8 weeks. Health-seeking delays differed by site and HIV status (Table 3, Fig 2 and S1b
Fig). Prolonged delays were most common among HIV-positive patients attending the tertiary
hospital—68.8% of such patients waited�4 weeks to seek care.
Table 2. Baseline characteristics by enrollment site and HIV status.
Overall First-level Hospital Tertiary Hospital








Age in years, median (IQR) 34 (27–42) 35 (30–39) 30 (25–38) 36 (30–45) 33 (26–46)
Sex
Male 275 (68.7) 46 (59.0) 145 (87.9) 53 (48.6) 31 (64.6)
Female 125 (31.3) 32 (41.0) 20 (12.1) 56 (51.4) 17 (35.4)
Education
None/primary 172 (42.9) 41 (52.6) 77 (46.4) 41 (37.6) 13 (27.1)
Secondary/tertiary 229 (57.1) 37 (47.4) 89 (53.6) 68 (62.4) 35 (72.9)
Relationship status
Currently married 192 (47.9) 43 (55.1) 73 (44.0) 59 (54.1) 17 (35.4)
Divorced or separated 49 (12.2) 20 (25.6) 20 (12.1) 5 (4.6) 4 (8.3)
Widowed 18 (4.5) 2 (2.6) 5 (3.0) 9 (8.3) 2 (4.1)
Unmarried 142 (35.4) 13 (16.7) 68 (41.0) 36 (33.0) 25 (52.1)
Medical history
HIV testing
Tested in last 12 months 273 (68.1) 23 (29.5) 161 (97.0) 46 (42.2) 43 (89.6)
Tested, but >12 months 124 (30.9) 55 (70.5) 5 (3.0) 61 (56.0) 3 (6.3)
Never tested 4 (1.0) 0 0 2 (1.8) 2 (4.2)
If HIV-positive, ART status
Current daily use 172 (92.5) 70 (89.7) - 102 (94.4) -
Current use, occasional missed doses 5 (2.7) 3 (3.9) - 2 (1.9) -
Naïve 9 (4.8) 5 (6.4) - 4 (3.7) -
If HIV-positive, attendance at ART clinic in last 3
months?
Yes 176 (95.1) 71 (91.0) - 105 (97.2) -
No 10 (5.4) 7 (9.0) - 3 (2.8) -
Previous history of tuberculosis
Yes 57 (14.2) 13 (16.9) 14 (8.4) 23 (21.2) 7 (14.6)
No 344 (85.8) 65 (83.3) 152 (91.6) 86 (78.9) 41 (85.4)




1400 (900–3000) 1500 (900–3000) 1600 (1000–3800) 2000 (1000–4000)
https://doi.org/10.1371/journal.pone.0252095.t002
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Diagnostic and treatment delays (system-related delays)
The median diagnostic delay (time to diagnosis) after patients first sought care was 1.7 (IQR,
0.9–3.0) weeks (Fig 2 and S1c Fig). The large majority (79.5%) of patients were diagnosed with
TB within 4 weeks of initially seeking care; however, 13.6% and 6.9% were diagnosed with TB
4–7.9 weeks and�8 weeks after first seeking care, respectively. Diagnostic delays were more
common among patients attending the first-level hospital, especially HIV-positive patients
(Table 3, Fig 2 and S1c Fig). Prolonged delays in initiation of TB therapy after establishing a
TB diagnosis were uncommon (Table 3, Fig 2); 91.5% of patients were initiated on therapy
within 2 days of diagnosis, whereas 5.2% were initiated on therapy 3–6 days after diagnosis,
and 3.2% were initiated on therapy�7 days after diagnosis. Treatment delays did not differ by
enrollment site or HIV status (Table 3).
Facilities visited and treatments received during TB care pathway
Overall, patients visited a median of 1 (IQR 1–2) provider/facility prior to their TB diagnosis
(S1 Table); however, 35.4% visited 2 providers/facilities and 8.2% made�3 different health-
care-related visits before their TB was diagnosed. When patients initially sought care for their
illness, 86.8% attended a public health facility, 7.8% visited a pharmacy, 4.5% visited a private
health facility and 1.0% sought care from a traditional healer. 75.6% of patients reported
receipt of antibiotics during the course of their illness and 8.7% reported that they had received
Fig 2. Tuberculosis patient care pathways in Zambia, according to HIV status by enrolment site.
https://doi.org/10.1371/journal.pone.0252095.g002
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a traditional remedy. The number of facilities visited, location of initial care-seeking and treat-
ments received did not substantially differ by enrollment site or HIV status (S1 Table).
Factors influencing TB health-seeking behaviors
More than half (54.1%) of TB patients reported that they had contemplated presenting to care
sooner than they did (S2 Table). Patients cited several reasons for delaying care-seeking,
including: they initially thought their symptoms weren’t serious (91.2%), they thought that
their symptoms were due to alternative causes such as weather or pollution (89.4%), they did
not know the symptoms of TB (79.3%), they preferred to first try self-medication and/or home
remedies (51.6%), and they lacked sufficient time due to work or caretaker responsibilities
(48.9%) (Fig 3a). Less commonly reported reasons for delayed care-seeking included: it shows
weakness, lack of social support, fear of discrimination/stigma and fear of being HIV-positive
(Fig 3a). HIV-positive patients attending the first-level hospital were more likely to state that a
fear of showing weakness influenced their delayed health-seeking (36.5 vs. 19.2%; p = 0.015),
whilst HIV-negative patients were more likely to state that their concern about either having
HIV or being required to test for HIV delayed initial care-seeking (16.7% vs. 3.9%; p = 0.021)
(S2 Table).
Patients reported many factors influencing their decision to ultimately seek care for their
illness, including: to stay healthy (96.8%), they feared it was something serious (91.8%),
friends/loved ones were worried (85.0%), they were very weak and debilitated (69.3%), they
Table 3. Overview of TB patient care pathway according to enrollment site and HIV status.














4.1 (3.1–9.7) 4.9 (3.0–8.0) 0.58 6.4 (4.7–8.9) 4.9 (3.6–6.7) 0.002
Total TB Pathway category
<4 weeks 119 (30.5) 27 (37.0) 63 (39.4) 0.21 15 (13.8) 14 (29.2) 0.06
4–7.9 weeks 158 (40.5) 23 (31.5) 52 (32.5) 57 (52.3) 26 (54.2)
8–11.9 weeks 71 (18.2) 10 (13.7) 31 (19.4) 25 (22.9) 5 (10.4)
�12 weeks 42 (10.8) 13 (17.8) 14 (8.8) 12 (11.0) 3 (6.3)




2.0 (1.0–3.0) 2.0 (1.0–4.0) 0.33 4.0 (3.0–6.0) 3.0 (2.0–5.0) 0.002
Health-seeking delay category
<4 weeks 229 (58.7) 59 (80.8) 111 (69.4) 0.18 34 (31.2) 25 (52.1) 0.039
4–7.9 weeks 118 (30.3) 9 (12.3) 34 (21.3) 56 (51.4) 19 (39.6)
�8 weeks 43 (11.0) 5 (6.9) 15 (9.4) 19 (17.4) 4 (8.3)




2.0 (0.9–6.3) 2.0 (1.0–3.9) 0.60 1.3 (0.9–2.4) 1.0 (0.9–2.0) 0.64
Diagnostic delay category
<4 weeks 310 (79.5) 51 (69.9) 120 (75.0) 0.030 96 (88.1) 43 (89.6) 0.60
4–7.9 weeks 53 (13.6) 9 (12.3) 29 (18.1) 10 (9.1) 5 (10.4)
�8 weeks 27 (6.9) 13 (17.8) 11 (6.9) 3 (2.8) 0
Treatment delay in days (median, IQR) 0 (0–0) 0 (0–1) 0 (0–0) 0.013 0 (0–0) 0 (0–0) 0.81
Treatment delay category
<3 days 367 (91.5) 69 (88.5) 147 (88.6) 0.81 106 (97.3) 45 (93.8) 0.37
3–6 days 21 (5.2) 4 (5.1) 11 (6.6) 3 (2.8) 3 (6.3)
�7 days 13 (3.2) 5 (6.4) 8 (4.8) 0 0
https://doi.org/10.1371/journal.pone.0252095.t003
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could no longer work (68.5%), to set a good example for friends and loved ones (58.5%) and
because they specifically feared that it could be TB (44.8%) (Fig 3b, S2 Table). TB patients
chose an initial provider/facility for evaluation and treatment of their illness because it: was
close to home (59.6%), offered good quality service (49.9%), offered privacy/confidentiality
(41.7%), provided inexpensive services (39.2%), had friendly providers (37.9%), was a place
their friends and/or loves ones went (36.7%), was a place they were familiar with (31.2%), and
offered short wait times (30.4%) (Fig 3c, S2 Table).
Patient preferences for improving TB services
Next, we determined patient preferences for improving TB diagnosis and care services.
Patients very strongly preferred same-day TB test results compared to being contacted by
phone with their results or returning another day to collect their results (Fig 4). They also
showed strong preferences for shorter times spent at the facility, a facility closer to their home,
a facility providing a financial incentive for undertaking TB testing and a facility that offered
greater privacy/confidentiality. Patients demonstrated weak preferences for the facility hours
of operation and the sex of their healthcare provider (Fig 4).
The most important service attribute was the speed/method of TB results (relative impor-
tance, 37.2%) (S2 Fig)—this was more than twice as important as the second and third most
important attributes—the total amount of time spent at a facility (18.0%), and a facility’s
Fig 3. Barriers and facilitators to tuberculosis care engagement in Zambia: (a) reasons for delayed health-seeking among patients who
contemplated presenting to care sooner than they did (n = 217); (b) reasons for seeking healthcare (n = 401); (c) reasons for choosing initial site/
facility for evaluation and care (n = 401).
https://doi.org/10.1371/journal.pone.0252095.g003
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proximity to their home (16.9%). In all sub-group analyses, the speed/method of TB results
was the most important service attribute (range of relative importance across sub-groups,
31.0–39.6%) (S3–S5 Tables); the total time spent at a facility (range, 17.3–18.7%) and a facility’s
proximity to home (range, 15.2–18.4%) also remained highly preferred attributes across all
sub-group analyses.
Patients were willing to travel up to 7.6 kilometers further or wait an additional 8.2 hours in
order to have access to a facility offering same-day TB test results (Fig 5). Patients were also
willing to travel further and wait longer for a facility that offered financial incentives to under-
take TB testing or a facility that provided enhanced confidentiality where they were unlikely to
be known/recognized by anyone (Fig 5).
Discussion
In this study among newly diagnosed TB patients in Lusaka, Zambia, we found that nearly
30% of patients had a TB care pathway that exceeded two months, and that prolonged care
pathways were predominantly due to patient-related, health-seeking delays. More than half of
patients said they had delayed health-seeking for which they reported several reasons and bar-
riers, including a lack of TB-specific knowledge and a lack of time due to competing responsi-
bilities. When asked about potential strategies to improve TB services that may facilitate earlier
engagement, patients expressed very strong preferences for a facility providing same-day TB
test results—they were willing to travel more than 7 kilometers further, or wait 8 hours longer
Fig 4. Patient preferences for improving tuberculosis care services in Zambia: The average utilities (zero-centered) for enhanced TB facility
features. Abbreviations: KM = kilometers, TB = tuberculosis, ZMK = Zambian Kwacha.
https://doi.org/10.1371/journal.pone.0252095.g004
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to access this feature. These results have important implications for future strategies to
improve TB diagnosis in high burden settings.
The median time from symptom onset to initiation of TB therapy among patients in our
study was 5 weeks. A study also conducted in Lusaka two decades ago found that the TB care
pathway was nearly 9 weeks [19]. While this suggests progress over the last 20 years, prolonged
TB care pathways in excess of 2–3 months remained common in our study and were most fre-
quently driven by patient-related delays in care-seeking. TB patients on average reported
Fig 5. Tradeoffs patients were willing to make in order to access a facility offering different enhanced services: (a) additional willingness to
travel (in kilometers), (b) additional willingness to wait (in hours). Willingness to travel and wait values were calculated using the following
assumptions for a “usual” tuberculosis health facility in Lusaka, Zambia: it is 2 kilometers from an individual’s home, requires two hours spent at
the clinic waiting and undergoing evaluation (based on the median amount of time cited by survey participants on their date of TB diagnosis), it is
only be open during typical business hours Monday through Friday, an individual may be known or recognized there, is does not offer sex-
concordant health care providers, it does not offer financial incentives for undergoing TB testing, and it requires individuals to return on a
different day to collect their TB test results. Because it is not feasible to implement same-day TB testing without an additional wait time for
patients, in the willingness’s to travel analyses, we assumed that patients would need to wait an additional 3 hours (minimum estimated time
required for sample collection and transport, Xpert testing, and result notification), or 6 hours (total wait time of 5 or 8 hours, respectively), in
order to access same-day TB testing.
https://doi.org/10.1371/journal.pone.0252095.g005
PLOS ONE TB care pathways and TB service preferences in Zambia
PLOS ONE | https://doi.org/10.1371/journal.pone.0252095 August 31, 2021 11 / 16
waiting 3 weeks before seeking care for their illness, but an important minority of 11% of
patients waited 8 or more weeks. It is increasingly recognized that a small proportion of people
with TB known as ‘superspreaders’ may contribute to the majority of community transmission
through prolonged periods of infectiousness and a large number of contacts [20]. Thus, com-
munity-based, active TB case finding strategies to identify such patients sooner are likely to be
an important component to improve TB control [21,22].
Several factors contributing to delayed healthcare-seeking behavior and TB diagnoses were
identified. Many patients who delayed care-seeking stated that they either didn’t initially think
their symptoms were serious and/or they didn’t know the symptoms of TB. This suggests the
need for ongoing community-targeted awareness activities to disseminate TB information and
education, including the individual and societal benefit of early TB diagnosis and treatment as
well as where to go for evaluation [23,24]. While less commonly reported by study participants,
a perception that it shows weakness to get help, fear of discrimination after TB diagnosis, and
a lack of social support contribute to TB health-seeking delays in this setting; additionally, 15–
30% of HIV-negative patients said they delayed care-seeking, in part because of a fear of having
HIV. This highlights the need to normalize healthy behaviors, prevent and mitigate TB- and
HIV-related stigma and improve social support as part of multicomponent strategies to facili-
tate earlier TB care engagement [25,26].
In addition to frequent and prolonged delays in health-seeking, once patients did seek care,
more than 40% visited two or more providers/facilities before being diagnosed with TB—fur-
ther prolonging the TB care pathway. Most of such patients (90%) first visited a clinic or hospi-
tal suggesting that their TB diagnosis was missed in at least one healthcare encounter. In high
prevalence settings, systematic TB screening of all individuals presenting to care for any rea-
son, may yield a large number of TB cases that may have otherwise been missed [27–30]. In
settings where this may not be feasible, facilities and TB control programs should focus on pri-
oritizing systematic TB screening among persons with a high risk of TB, including, PLHIV,
persons with diabetes, close contacts of TB patients and individuals with a prior history of TB
treatment [30,31]. Implementation strategies to facilitate broader uptake of this should be eval-
uated. Prompt initiation of TB treatment following diagnosis was a programmatic strength of
facilities included in our study as 92% of patients started TB treatment within two days of
diagnosis.
PLHIV attending a large, tertiary referral hospital had substantially longer TB care path-
ways compared to HIV-negative TB patients attending the same facility as well as PLHIV
attending a first-level hospital. These differences were largely accounted for by delays in ini-
tial health-seeking. The reasons provided for delaying care-seeking did not differ according
to HIV status and there were also no differences in HIV care engagement services by enrol-
ment site. Thus, it is not clear why such patients were more likely to delay their care-seeking.
PLHIV attending the tertiary hospital may have been more likely to have advanced immuno-
deficiency resulting in non-specific symptoms that were initially overlooked and/or caused
them to wait because they were not felt be serious; however, we were unable evaluate this
possibility as CD4 counts were not systematically determined. To reduce preventable suffer-
ing and deaths due to TB among PLHIV, further scale-up of collaborative TB and HIV ser-
vices are needed [32,33].
Among potential strategies to improve TB services and accelerate care engagement, TB
patients expressed very strong preferences for same-day TB test results. The availability of
same-day TB results was more than twice as preferred as the next most preferred improve-
ment strategy (total time spent at a facility) and was the most preferred TB service attribute,
regardless of HIV status, sex, or the time to initial care-seeking. We also found that patients
would be willing to travel substantially further (more than 7 additional kilometers) or wait
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substantially longer (more than 8 additional hours) in order to access a health facility provid-
ing same-day TB test results. In addition to being a convenient, patient-centered strategy
that could facilitate earlier care-seeking, same-day TB testing and treatment initiation
reduces diagnostic and treatment delays as well as pre-treatment loss-to-follow-up [34,35]; it
may also reduce prolonged periods of infectiousness among those with untreated TB [35].
Xpert/Xpert Ultra is currently recommended as a first-line TB diagnostic test due to its sub-
stantially improved sensitivity over smear microscopy and its ability to simultaneously detect
rifampicin resistance [36]; however, due to cost and infrastructure requirements, Xpert test-
ing machines are often not available on site, especially at lower healthcare facility levels, and
results are therefore rarely available the same-day [37]. Development and implementation of
rapid, accurate, point-of-care triage tests [31,38] and confirmatory tests [39,40] among pre-
sumptive TB patients in high-burden settings could facilitate same-day rule-out or confirma-
tion of TB, respectively.
TB patients also voiced strong preferences for shorter wait times and facilities close to their
home. In addition to same-day test results, these attributes each relate to a reduction in time
spent seeking care and evaluation and imply the value that socioeconomically vulnerable indi-
viduals place on their time. Therefore, additional strategies that could facilitate earlier TB
detection may include decentralization of TB services to community clinics (e.g., health posts
as part of a hub and spoke model) as well as TB fast-track points at health facilities where
close contacts and individuals with TB symptoms can skip the regular que and undergo rapid
screening and testing for TB [28].
Strengths of this study include the inclusion of a large number of consecutive, newly diag-
nosed TB patients from two different levels of healthcare facilities. There are however some
study limitations. Health-seeking delays were based upon patients’ self-report and may be sub-
ject to either recall or desirability bias. While patients’ TB care pathways and TB service prefer-
ences are likely representative of individuals in Lusaka Province, which accounts for at least
40% of Zambia’s TB cases [41], individuals from additional regions in Zambia, including
rural settings were not included. Finally, although we intentionally included patients present-
ing to a tertiary hospital as a proxy for very delayed care-seeking, this study does not account
for patients who never sought care for their TB illness.
In conclusion, among newly diagnosed TB patients in a high TB/HIV setting, prolonged
TB care pathways were common and were predominantly driven by patients’ delays in health-
seeking after symptom onset. Among potential strategies to facilitate earlier TB care engage-
ment, patients strongly preferred TB facilities that offered same-day TB test results. To detect
more TB cases and identify them sooner, future interventions must address local barriers to
care engagement, and should directly incorporate patients’ preferences, especially same-day
TB test results.
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